| Dr Karen Elizabeth Dickes, DO | |
|
415 W 3rd St, Yankton, SD 57078-4201 | |
| (605) 665-9638 | |
| (605) 665-0526 |
| Full Name | Dr Karen Elizabeth Dickes |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 17 Years |
| Location | 415 W 3rd St, Yankton, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487851754 | NPI | - | NPPES |
| 363050195-13 OR -14 | Medicaid | NE | |
| 6300740 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 822 (Nebraska) | Secondary |
| 207W00000X | Ophthalmology | 8060 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Windom Area Health | Windom, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ophthalmology Ltd | 0547152571 | 13 |
| Ophthalmology Ltd | 0547152571 | 13 |
News Archive
A new study adds to the sum of knowledge around this issue, showing a highly synchronized and rapid development of an antibody response in breast milk and serum, which reached stable levels around two weeks after the second dose of the vaccine was administered.
For years, confusion has surrounded the conditions under which older adults can receive physical, occupational and speech therapy covered by Medicare.
In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist (MRA) called finerenone was no more effective than the currently approved MRA eplerenone in reducing the heart failure biomarker N-terminal pro-B-type natriuretic peptide [NT-proBNP].
Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer's disease, Parkinson's disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive technology.
› Verified 2 days ago
| Entity Name | Ophthalmology Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871589531 PECOS PAC ID: 0547152571 Enrollment ID: O20040325001333 |
News Archive
A new study adds to the sum of knowledge around this issue, showing a highly synchronized and rapid development of an antibody response in breast milk and serum, which reached stable levels around two weeks after the second dose of the vaccine was administered.
For years, confusion has surrounded the conditions under which older adults can receive physical, occupational and speech therapy covered by Medicare.
In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist (MRA) called finerenone was no more effective than the currently approved MRA eplerenone in reducing the heart failure biomarker N-terminal pro-B-type natriuretic peptide [NT-proBNP].
Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer's disease, Parkinson's disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive technology.
› Verified 2 days ago
| Entity Name | Ophthalmology Ltd Eye Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871581876 PECOS PAC ID: 1557357175 Enrollment ID: O20040421000731 |
News Archive
A new study adds to the sum of knowledge around this issue, showing a highly synchronized and rapid development of an antibody response in breast milk and serum, which reached stable levels around two weeks after the second dose of the vaccine was administered.
For years, confusion has surrounded the conditions under which older adults can receive physical, occupational and speech therapy covered by Medicare.
In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist (MRA) called finerenone was no more effective than the currently approved MRA eplerenone in reducing the heart failure biomarker N-terminal pro-B-type natriuretic peptide [NT-proBNP].
Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer's disease, Parkinson's disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive technology.
› Verified 2 days ago
| Entity Name | Willcockson Eye Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992802920 PECOS PAC ID: 8729047295 Enrollment ID: O20041008001120 |
News Archive
A new study adds to the sum of knowledge around this issue, showing a highly synchronized and rapid development of an antibody response in breast milk and serum, which reached stable levels around two weeks after the second dose of the vaccine was administered.
For years, confusion has surrounded the conditions under which older adults can receive physical, occupational and speech therapy covered by Medicare.
In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist (MRA) called finerenone was no more effective than the currently approved MRA eplerenone in reducing the heart failure biomarker N-terminal pro-B-type natriuretic peptide [NT-proBNP].
Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer's disease, Parkinson's disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive technology.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karen Elizabeth Dickes, DO 6601 S Minnesota Ave Ste 200, Sioux Falls, SD 57108-2564 Ph: (605) 336-6294 | Dr Karen Elizabeth Dickes, DO 415 W 3rd St, Yankton, SD 57078-4201 Ph: (605) 665-9638 |
News Archive
A new study adds to the sum of knowledge around this issue, showing a highly synchronized and rapid development of an antibody response in breast milk and serum, which reached stable levels around two weeks after the second dose of the vaccine was administered.
For years, confusion has surrounded the conditions under which older adults can receive physical, occupational and speech therapy covered by Medicare.
In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist (MRA) called finerenone was no more effective than the currently approved MRA eplerenone in reducing the heart failure biomarker N-terminal pro-B-type natriuretic peptide [NT-proBNP].
Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer's disease, Parkinson's disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive technology.
› Verified 2 days ago
Paula Ann Hicks, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 415 W 3rd St, Yankton, SD 57078 Phone: 605-665-9638 Fax: 605-665-0526 | |
Patrick Holt King, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 415 W 3rd St, Yankton, SD 57078 Phone: 605-665-9638 Fax: 605-665-0526 | |
Trevor Kindle, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 415 W 3rd St, Yankton, SD 57078 Phone: 605-665-9638 Fax: 605-665-0526 |